Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jahn

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Biological Chemistry|August 30, 2001
Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cellsJ Wiltfang, H Esselmann, P Cupers, et al.
Neuron|February 22, 2001
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampusS M Stobrawa, T Breiderhoff, S Takamori, et al.
Neurology|May 20, 2009
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCIF Jessen, O Gür, W Block, et al.
The Journal of Nutrition, Health & Aging|June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCIO Peters, D Lorenz, A Fesche, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
Molecular Psychiatry|October 13, 2006
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietinH Ehrenreich, D Hinze-Selch, S Stawicki, et al.
Experimental Neurology|August 12, 2009
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexingP Lewczuk, J Kornhuber, E Vanmechelen, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Biological Chemistry|August 30, 2001
Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cellsJ Wiltfang, H Esselmann, P Cupers, et al.
Neuron|February 22, 2001
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampusS M Stobrawa, T Breiderhoff, S Takamori, et al.
Neurology|May 20, 2009
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCIF Jessen, O Gür, W Block, et al.
The Journal of Nutrition, Health & Aging|June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCIO Peters, D Lorenz, A Fesche, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
Molecular Psychiatry|October 13, 2006
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietinH Ehrenreich, D Hinze-Selch, S Stawicki, et al.
Experimental Neurology|August 12, 2009
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexingP Lewczuk, J Kornhuber, E Vanmechelen, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Pageof 8